MiR-877 suppresses tumor metastasis via regulating FOXM1 in ovarian cancer

被引:1
|
作者
Fang, Lei [1 ]
Zhang, Bobo [2 ]
Zhu, Ning [3 ]
机构
[1] Dongda Hosp, Dept Oncol, Shanxian, Heze, Peoples R China
[2] Haijiya Hosp, Dept Oncol, Shanxian, Heze, Peoples R China
[3] Dongda Hosp, Dept Pathol, Shanxian, Heze, Peoples R China
来源
JOURNAL OF BUON | 2021年 / 26卷 / 01期
关键词
ovarian cancer; miR-877; migration; invasion; FOXM1; COLORECTAL-CANCER; MICRORNAS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Ovarian cancer (OC) is a serious threat to women's life. OC is insidious and lacks early diagnosis and effective treatment. Therefore, it is vital to look for new therapeutic targets and biomarkers. Methods: MicroRNA-877 (miR-877) expression level in OC was accessed via quantitative real-time polymerase chain reaction (qRT-PCR). Transwell assay, Matrigel assay and wound healing assay were used to analyze the ability of miR-877 on cell migration and invasion. Luciferase reporter assay was employed for verification the target of miR-877. Western blotting was taken in for the determination of the expression level of FOXM1. Results: MiR-877 had low expression level in OC tissues and cell lines. MiR-877 over-expression induced inhibition of cell migration and invasion. FOXM1 was a direct target of miR-877. MiR-877 restrained cell migration and invasion by negatively regulating FOXM1 expression in OC. Conclusions: Our research elucidated that miR-877 played a role of tumor suppressor in OC by negatively regulating FOXM1 which may bring a novel insight into new molecular therapeutic targets and biomarkers for OC.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [1] miR-877-5p Suppresses Gastric Cancer Cell Proliferation Through Targeting FOXM1
    Wu, Kun
    Yu, Zhu
    Tang, Zhenyong
    Wei, Weiyuan
    Xie, Dongyi
    Xie, Yubo
    Xiao, Qiang
    ONCOTARGETS AND THERAPY, 2020, 13 : 4731 - 4742
  • [2] Long non-coding RNA (CMR) involved in autoprotection in S. aureus mastitis in dairy cows by regulating miR-877/FOXM1
    Chu, Shuangfeng
    Zhao, Tianqi
    Li, Mingxun
    Sun, Yujia
    Yang, Yi
    Yang, Zhangping
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 278
  • [3] Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer
    Kopanja, Dragana
    Chand, Vaibhav
    O'Brien, Eilidh
    Mukhopadhyay, Nishit K.
    Zappia, Maria P.
    Islam, Abul B. M. M. K.
    Frolov, Maxim, V
    Merrill, Bradley J.
    Raychaudhuri, Pradip
    CANCER RESEARCH, 2022, 82 (13) : 2458 - 2471
  • [4] Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1
    Huang, Xinli
    Qin, Jianjie
    Lu, Sen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1515 - 1524
  • [5] MiR-877 suppresses gastric cancer progression by downregulating AQP3
    Zhu, Hongyu
    Wu, Yulian
    Kang, Muxing
    Zhang, Bo
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (06)
  • [6] FoxM1: A Master Regulator of Tumor Metastasis
    Raychaudhuri, Pradip
    Park, Hyun Jung
    CANCER RESEARCH, 2011, 71 (13) : 4329 - 4333
  • [7] FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
    Zhou, Jinhua
    Wang, Yunfei
    Wang, You
    Yin, Xia
    He, Yifeng
    Chen, Lilan
    Wang, Wenwen
    Liu, Ting
    Di, Wen
    PLOS ONE, 2014, 9 (05):
  • [8] Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway
    Yan, J.
    Hou, J.
    Yan, Y.
    Ren, X-Y
    Luo, H-N
    Wang, Z-G
    Zheng, G-X
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (12) : 6786 - 6793
  • [9] miR-877-5p alleviates chondrocyte dysfunction in osteoarthritis models via repressing FOXM1
    Zhu, Shaobo
    Deng, Yu
    Gao, Hui
    Huang, Kaiyuan
    Nie, Zhongjie
    JOURNAL OF GENE MEDICINE, 2020, 22 (11):
  • [10] Analyses of FOXM1 isoforms in ovarian cancer
    Altadill, Tatiana
    Rigau, Marina
    Majem, Blanca
    Lanau, Lucia
    Castellv, Josep
    Garcia, Angel
    Perez-Benavente, Assumpcio
    Luis Sanchez, Jose
    Cabrera, Silvia
    Xercavins, Jordi
    Maria del Campo, Josep
    Gil-Moreno, Antonio
    Llaurado, Marta
    Reventos, Jaume
    CLINICAL CANCER RESEARCH, 2013, 19